AllSight
Companies · SCTX · Biological Products, (No Diagnostic Substances)
Scribe Therapeutics, Inc. (SCTX)
Scribe Therapeutics, Inc. (SCTX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Sep 2, 2026Beat
Scribe Therapeutics posts Q2 EPS beat, but collaboration revenue falls sharply
Related companies in Biological Products, (No Diagnostic Substances)
About AllSight · Editorial standards & method · Contact